ArticleOphthalmology science2026

Results from a Phase I Extension Study of Ciliary Neurotrophic Factor in Patients with Macular Telangiectasia Type 2.

Lawrence J Singerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.